June 8, 2022
Clinical researchers, seeking to understand the statistical benefits of a common Phase 2 oncology design, now have a..
June 7, 2022
In most instances of blinded sample size re-estimation, the timing of the interim analysis that determines whether the..
April 5, 2022
Hello! I’m delighted to pen my inaugural blog post here as Cytel’s Chief Medical Officer. In this series, we’ll explore..
May 12, 2020
In our previous blog, “Remote Working Arrangement – How to get it right?”, we talked about how the need for social..
May 7, 2020
An extraordinary amount of global research is underway as the COVID-19 pandemic continues to evolve and spread..
May 5, 2020
Cytel's team of oncology trial design and advanced analytics experts are hosting a series of complimentary webinars..
April 23, 2020
Cytel is hosting a webinar, “A Clinician’s Perspective on Cancer Drugs Development”, on April 28, 2020. Our speaker,..
February 28, 2019
In honor of Rare Disease Day 2019 we share a new Cytel podcast featuring Cytel Strategic Consultant Ursula Garczarek..